Hester Biosciences gains on reporting 22% rise in Q3 net profit

19 Jan 2017 Evaluate

Hester Biosciences is currently trading at Rs. 739.10, up by 1.75 points or 0.24% from its previous closing of Rs. 737.35 on the BSE.

The scrip opened at Rs. 746.00 and has touched a high and low of Rs. 757.00 and Rs. 734.50 respectively. So far 7,018 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 825.00 on 29-Jul-2016 and a 52 week low of Rs. 337.00 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 757.00 and Rs. 725.00 respectively. The current market cap of the company is Rs. 628.00 crore.

The promoters holding in the company stood at 54.07%, while Institutions and Non-Institutions held 1.83% and 44.10% respectively.

The company has reported 21.85% rise in its net profit at Rs 5.80 crore for third quarter ended December 31, 2016 as compared to Rs 4.76 crore for the same quarter in the previous year. Total income from operation of the company increased by 17.95% at Rs 28.52 crore for Q3FY17 as compared Rs 24.18 crore for the corresponding quarter previous year. 

Hester Biosciences is one of India’s leading animal healthcare companies and second largest poultry vaccine manufacturer. Located near Ahmedabad, Gujarat, Hester has a state-of-the-art manufacturing facility for products ranging from vaccines, health products to diagnostics. Hester’s services include seroprofiling for poultry flocks and mastitis control programs for cattle.


Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×